These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. Steadham JE, Stall SK, Simmank JL. Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885 [Abstract] [Full Text] [Related]
13. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis. Ashtekar DR, Costa-Periera R, Shrinivasan T, Iyyer R, Vishvanathan N, Rittel W. Diagn Microbiol Infect Dis; 1991 Jan; 14(6):465-71. PubMed ID: 1802533 [Abstract] [Full Text] [Related]
14. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing]. Tsukamura M. Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008 [Abstract] [Full Text] [Related]
15. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin]. Tsukamura M. Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046 [Abstract] [Full Text] [Related]